Description

Stryker Corporation: Leveraging Mako Robotic-Assisted Surgeries To Redefine the Industry!

Stryker Corporation reported strong financial performance in its fourth quarter of 2024 and the full fiscal year, demonstrating resilience and robust growth across its business segments. The company’s organic sales growth exceeded 10% for both periods, with U.S. sales growth at 10.6% and international sales at 8.8%. Key drivers included double-digit growth in the Instruments, Endoscopy, Medical, Neuro Cranial, and Trauma and Extremities businesses.

Our Report Structure:

⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures

Want unlimited access to our reports? Purchase our $99 annual subscription!